The Nifty extended its losing streak with a sixth consecutive decline, slipping below the 25,000 support level amid broad-based selling, especially in pharma and IT stocks. Analysts warn of further downside if 24,500 breaks, though a recovery remains possible. Stock recommendations include Ashok Leyland, Dr Agarwal’s Health Care, Dixon, and Anant Raj.
Global markets: Stocks slip as dollar heads for weekly loss
In a week fraught with concerns over escalating interest rates and financial complications tied to AI, global stock indices saw moderate declines. While the S&P
October 17, 2026